Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort studyWouter Froyman, D. Timmerman, A. C. Testa et al.|The Lancet Oncology|2019Cited by 188
Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort studyBen Van Calster, D. Timmerman, L. Valentin et al.|BMJ|2020Cited by 124